Get all your news in one place.
100’s of premium titles.
One app.
Start reading
The Hindu
The Hindu
National
Special Correspondent

Rahul lobbying for pharma firms, says Ravi Shankar Prasad

Union Minister Ravi Shankar Prasad. File (Source: AFP)

Union Law Minister Ravi Shankar Prasad on Friday accused Congress leader Rahul Gandhi of lobbying for pharma companies after the latter’s letter to Prime Minister Modi on vaccine shortages, seeking fast track approvals for other vaccine candidates.

Mr. Gandhi’s letter followed a rather acrimonious exchange of words between the Centre and the Maharashtra government on vaccine shortages and vaccination rates.

Mr. Prasad’s response to the Congress leader’s letter came in a series of tweets.

“After failing as a part-time politician, has Rahul Gandhi switched to full time lobbying? First he lobbied for fighter plane companies by trying to derail India’s acquisition programme. Now he is lobbying for pharma companies by asking for arbitrary approvals for foreign vaccines,” he tweeted adding that fighting a pandemic wasn’t a “one trick game”.

“Fighting a pandemic is not a one trick game. Apart from vaccination, there needs to be adequate focus on testing, tracing & treating. Rahul Gandhi’s problem is that he doesn’t understand all this and his ignorance is compounded by his arrogance,” the Minister added.

Referring to charges of vaccine shortages, Mr. Prasad said “Congress-ruled States” had a problem with “basic commitment towards health care”.

“He should write letters to his party’s governments to stop their vasooli (extortion) ventures & concentrate on administering the lakhs of vaccines they are sitting upon,” he said.

He also termed Mr. Gandhi as attention-seeking and asked why he hadn’t taken the vaccination himself, or whether it was “an oversight or he doesn’t want it or has he already taken one in many of his undisclosed trips to foreign locations but doesn’t want to disclose?”

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.